Please login to the form below

Not currently logged in
Email:
Password:

Lab21 buys Myconostica

Personalised medicine firm Lab21 has acquired Myconostica, a molecular diagnostic company focusing on the diagnosis of fungal infections, for an undisclosed sum

Personalised medicine firm Lab21 has acquired Myconostica, a molecular diagnostic company focusing on the diagnosis of fungal infections, for an undisclosed sum.

The acquisition provides the company's first set of nucleic acid-based assays and will provide manufacturing capabilities to develop and produce its range of new biomarker assays.

Lab21 will launch the Myconostica fungal testing services from its new reference laboratory in South Carolina, as well as its laboratory in Cambridge, UK.

Graham Mullis, chief executive of Lab21, said: "We are delighted that we have acquired Myconostica. The company's products complement our infectious diseases portfolio and help position the Company in a large market where there are significant clinical challenges."

The deal is Lab21's sixth acquisition in the past two years.

Myconostica has three products on the market in Europe, Canada and Southern Africa, which were launched in 2010. These include a product for extracting fungal DNA from human samples and tests for the detection of Aspergillus and Pneumocystis jirovecii.

23rd May 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS LYNX

Welcome to HAVAS LYNX, a leading global healthcare communications group....

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics